The only study currently published in cutaneous localizations of AITL is the one of Leclaire Alirkilicarslan et al., which included 41 patients and found IDH2 R172K/S and RHOA G17V mutations in 19% and 78% of cases respectively17. Here, IDH2 is linked to angioimmunoblastic T-cell lymphoma.